We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s drug pricing watchdog has recommended reimbursement for Eli Lilly’s lung cancer drug Alimta and Pfizer’s leukemia therapy Bosulif at discounted prices. Read More
The FDA recommends drugmakers implementing the structured product labeling format for risk evaluation and mitigation strategies start by assembling its experts in both areas. Read More
Drugmakers submitting ANDAs for new drug strengths face FDA refusals due to insufficient justifications for impurities in the products, the agency says. Read More